Literature DB >> 34631363

Effects of Acute Drug Administration on Emotion: A Review of Pharmacological MRI Studies.

Kathryne Van Hedger1, Leah M Mayo2, Anya K Bershad3, Racheal Madray4, Harriet de Wit5.   

Abstract

PURPOSE OF REVIEW: Many drug users claim to use drugs to cope with negative emotions, which may, in turn, result in persistent emotional blunting or anhedonia even when they are not using drugs. The purpose of this review is to describe the ways acute administration of psychoactive drugs impacts brain regions during emotion-related tasks, as a first step in understanding how drugs influence emotion processing in the brain. RECENT
FINDINGS: Drugs have varying effects on neural responses to emotional stimuli. In general, alcohol, analgesics, and psychedelics reduce neural reactivity to negative emotional stimuli in the amygdala and other brain regions. Other drugs produce mixed effects: Stimulants such as caffeine and modafinil increase brain activation while viewing emotional stimuli, whereas MDMA decreases activation during presentation of negative images. The effects of cannabinoids (cannabidiol and THC) are mixed. There are also inconsistent findings on the associations between neural responses to emotional stimuli and subjective drug effects.
SUMMARY: Consistent with the notion that individuals might use drugs non-medically to diminish the experience of negative emotions, several drugs of abuse decrease neural responses to negative stimuli in limbic brain regions. These neural actions may underlie the reported 'emotional blunting' of drugs, which may contribute to drug-seeking behavior. Future work is needed to examine these limbic responses in relation to self-reports of changes in affect, both during acute administration and after extended drug use.

Entities:  

Keywords:  Alcohol; Analgesics; Cannabinoids; Emotion; Stimulants; phMRI

Year:  2021        PMID: 34631363      PMCID: PMC8494189          DOI: 10.1007/s40429-021-00362-y

Source DB:  PubMed          Journal:  Curr Addict Rep


  50 in total

1.  Effects of buprenorphine on responses to social stimuli in healthy adults.

Authors:  Anya K Bershad; Jacob A Seiden; Harriet de Wit
Journal:  Psychoneuroendocrinology       Date:  2015-09-12       Impact factor: 4.905

Review 2.  Cognitive deficits in individuals with methamphetamine use disorder: A meta-analysis.

Authors:  Stéphane Potvin; Julie Pelletier; Stéphanie Grot; Catherine Hébert; Alasdair M Barr; Tania Lecomte
Journal:  Addict Behav       Date:  2018-01-31       Impact factor: 3.913

3.  Affect dynamics of facial EMG during continuous emotional experiences.

Authors:  Yulia Golland; Adam Hakim; Tali Aloni; Stacey Schaefer; Nava Levit-Binnun
Journal:  Biol Psychol       Date:  2018-10-06       Impact factor: 3.251

4.  Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers.

Authors:  Rainer Kraehenmann; Katrin H Preller; Milan Scheidegger; Thomas Pokorny; Oliver G Bosch; Erich Seifritz; Franz X Vollenweider
Journal:  Biol Psychiatry       Date:  2014-04-26       Impact factor: 13.382

5.  Alcohol attenuates activation in the bilateral anterior insula during an emotional processing task: a pilot study.

Authors:  Claudia B Padula; Alan N Simmons; Scott C Matthews; Shannon K Robinson; Susan F Tapert; Marc A Schuckit; Martin P Paulus
Journal:  Alcohol Alcohol       Date:  2011-06-10       Impact factor: 2.826

6.  Acetaminophen reduces social pain: behavioral and neural evidence.

Authors:  C Nathan Dewall; Geoff Macdonald; Gregory D Webster; Carrie L Masten; Roy F Baumeister; Caitlin Powell; David Combs; David R Schurtz; Tyler F Stillman; Dianne M Tice; Naomi I Eisenberger
Journal:  Psychol Sci       Date:  2010-06-14

7.  Effects of Ketamine on Brain Activity During Emotional Processing: Differential Findings in Depressed Versus Healthy Control Participants.

Authors:  Jessica L Reed; Allison C Nugent; Maura L Furey; Joanna E Szczepanik; Jennifer W Evans; Carlos A Zarate
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2019-01-25

Review 8.  Opioid system and human emotions.

Authors:  Lauri Nummenmaa; Lauri Tuominen
Journal:  Br J Pharmacol       Date:  2017-05-24       Impact factor: 8.739

9.  Cannabinoid modulation of amygdala reactivity to social signals of threat in humans.

Authors:  K Luan Phan; Mike Angstadt; Jamie Golden; Ikechukwu Onyewuenyi; Ana Popovska; Harriet de Wit
Journal:  J Neurosci       Date:  2008-03-05       Impact factor: 6.167

10.  Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties.

Authors:  Lara Sharpe; Justin Sinclair; Andrew Kramer; Michael de Manincor; Jerome Sarris
Journal:  J Transl Med       Date:  2020-10-02       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.